Alnylam Pharmaceuticals, Inc.Cambridge, MA, United States (NASDAQ (GM): ALNY)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Alnylam Income Statement

All amounts in millions of except per share amounts.
View: Annual | Quarterly
Dec 07 Dec 06 Dec 05
Revenue 50.9 26.9 5.7
Cost of Goods Sold -- -- --
Gross Profit -- -- --
Gross Profit Margin 0.0% 0.0% 0.0%
SG&A Expense 140.0 62.6 46.1
Depreciation & Amortization 4.1 3.8 3.1
Operating Income (93.2) (39.5) (43.5)
Operating Margin -- -- --
Nonoperating Income 15.1 5.9 1.5
Nonoperating Expenses 1.1 1.0 1.0
Income Before Taxes (80.2) (34.6) (42.9)
Income Taxes 5.2 -- --
Net Income After Taxes (85.5) (34.6) (42.9)

Continuing Operations (85.5) (34.6) (42.9)
Discontinued Operations -- -- --
Total Operations (85.5) (34.6) (42.9)
Total Net Income (85.5) (34.6) (42.9)
Net Profit Margin -- -- --

Diluted EPS from Total Net Income ($) (2.21) (1.09) (1.96)
Dividends per Share -- -- --
Edgar Online logo
This data is provided as per license from EDGAR Online